On the 16th of June, 2024, Tesla Bioscience was granted the USPTO patent no.: US 12,037,302 B1 titled: “COMPOUND FOR TREATMENT OF BACTERIAL INFECTIONS OF DIFFERENT ETIOLOGY IN HUMANS”
The patent text can be viewed using the following link: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12037302
Granted US Patent
